← XCHG Ltd
| Annual Trend | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
| Net Income From Continuing Operations | — | $1.6m | ($8.1m) | ($11.9m) | ($32.5m) | ($32.5m) | |
| Net loss | — | $1.6m | ($8.1m) | ($11.9m) | ($32.5m) | — | |
| Net Income (Loss) Available to Common Stockholders, Basic | — | $1.6m |
($10.5m)
-749.77%
|
$0
+100.00%
|
$0 | — | |
| Depreciation, Depletion and Amortization | — | $138k | $203k | $233k | $275k | $275k | |
| Amortization of Intangible Assets | — | — | $30k | $27k | $0 | — | |
| Depreciation | — | $138k | $173k | $206k | $275k | $275k | |
| Depreciation Amortization Depletion | — | $138k | $203k | $233k | $275k | $275k | |
| Deferred Income Tax Expense (Benefit) | — | — | — | — | $0 | — | |
| Share-based Payment Arrangement, Noncash Expense | — | — | $7.5m | $7.0m | $20.9m | $20.9m | |
| Share-based Payment Arrangement, Expense | — | — | $7.5m | $7.0m | $20.9m | $20.9m | |
| Share-based compensation | — | — | $7.5m | $7.0m | $20.9m | $20.9m | |
| Asset Impairment Charge | — | $272k | $474k | $464k | $532k | $532k | |
| Income (Loss) from Equity Method Investments | — | — | — | — | $12k | — | |
| Changes in operating assets and liabilities: | |||||||
| Change In Working Capital | — | ($1.2m) | ($7.1m) | ($3.2m) | $3.1m | $3.1m | |
| Increase (Decrease) in Accounts Receivable | — | — | $5.1m | ($668k) | ($4.7m) | $4.0m | |
| Accounts receivable | — | ($3.6m) | ($5.1m) | $668k | $4.7m | $4.0m | |
| Change In Receivables | — | ($3.9m) | ($5.5m) | ($662k) | $4.0m | $4.0m | |
| Changes In Account Receivables | — | ($3.6m) | ($5.1m) | $668k | $4.7m | $4.0m | |
| Increase (Decrease) in Inventories | — | — | $663k | $1.3m | $1.8m | ($1.8m) | |
| Inventory Write-down | — | — | $156k | $43k | $5k | — | |
| Write-down of inventories | — | $0 | $156k | $43k | $5k | — | |
| Inventories | — | ($3.4m) | ($663k) | ($1.3m) | ($1.8m) | ($1.8m) | |
| Change In Inventory | — | ($3.4m) | ($663k) | ($1.3m) | ($1.8m) | ($1.8m) | |
| Increase (Decrease) in Accounts Payable | — | $4.1m | ($860k) | $2.4m | ($2.1m) | ($2.1m) | |
| Change In Payables And Accrued Expense | — | $5.5m | $755k | $1.9m | ($2.1m) | ($2.1m) | |
| Accrued expenses and other current liabilities | — | $1.5m | $1.6m | ($689k) | ($35k) | — | |
| Change In Accrued Expense | — | $1.5m | $1.6m | ($689k) | ($35k) | ($35k) | |
| Prepayments and other assets | — | ($410k) | $167k | ($4.7m) | $2.9m | — | |
| Change In Other Current Liabilities | — | ($277k) | ($274k) | ($370k) | ($540k) | ($540k) | |
| Net Cash Provided by (Used in) Operating Activities | — | $849k |
($5.6m)
-756.95%
|
($7.2m)
-29.16%
|
($7.5m)
-4.51%
|
($7.5m)
0.00%
|
|
| Cash flows from investing activities: | |||||||
| Gain (Loss) on Disposition of Property Plant Equipment | — | $8k | ($2k) | — | — | ($546k) | |
| Cash paid for purchase of property and equipment and intangible assets | — | ($214k) | ($526k) | ($614k) | ($677k) | — | |
| Net Other Investing Changes | — | $1.4m | $2.8m | $80k | ($822k) | ($822k) | |
| Net Cash Provided by (Used in) Investing Activities | — | $1.2m | $2.3m | ($534k) | ($1.5m) | ($1.5m) | |
| Cash flows from financing activities: | |||||||
| Gain (Loss) on Extinguishment of Debt | — | — | — | $233k | — | — | |
| Proceeds from short-term bank borrowings | — | $6.4m | $6.3m | $8.5m | $4.2m | — | |
| Repayment of short-term bank borrowings | — | ($3.8m) | ($4.6m) | ($7.3m) | ($6.8m) | — | |
| Issuance Of Debt | — | $6.4m | $17.4m | $15.5m | $4.2m | $4.2m | |
| Net Issuance Payments Of Debt | — | $2.6m | $12.7m | $1.3m | ($2.6m) | ($2.6m) | |
| Net Short Term Debt Issuance | — | $2.6m | $12.7m | $1.3m | ($2.6m) | ($2.6m) | |
| Short Term Debt Issuance | — | $6.4m | $17.4m | $15.5m | $4.2m | $4.2m | |
| Repayment Of Debt | — | ($3.8m) | ($4.6m) | ($14.3m) | ($6.8m) | ($6.8m) | |
| Short Term Debt Payments | — | ($3.8m) | ($4.6m) | ($14.3m) | ($6.8m) | ($6.8m) | |
| Issuance Of Capital Stock | — | $0 | $0 | $19.1m | $0 | $0 | |
| Repurchase Of Capital Stock | ($181k) | $0 | $0 | — | — | — | |
| Proceeds from Issuance of Common Stock | — | — | — | $19.1m | — | $0 | |
| Common Stock Issuance | — | $0 | $0 | $19.1m | $0 | $0 | |
| Net Other Financing Charges | — | ($365k) | ($2.0m) | ($1.2m) | ($1.8m) | ($1.8m) | |
| Net Cash Provided by (Used in) Financing Activities | — | $2.3m |
$10.7m
+371.57%
|
$19.1m
+78.25%
|
($4.3m)
-122.60%
|
($4.3m)
0.00%
|
|
| Net increase (decrease) in cash, cash equivalents and restricted cash | — | $3.8m | $7.0m | $11.1m | ($12.9m) | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | $7.0m | $11.1m | ($12.9m) | $13.9m | |
| Beginning Cash Position | — | $4.8m | $8.7m | $15.7m | $26.8m | $26.8m | |
| Cash, cash equivalents and restricted cash at the beginning of the year | — | $8.7m | $15.7m | $26.8m | $13.9m | — | |
| Effect of foreign currency exchange rate changes on cash and cash equivalents and restricted cash | — | ($507k) | ($411k) | ($333k) | $487k | — | |
| Effect Of Exchange Rate Changes | — | ($507k) | ($411k) | ($333k) | $487k | $487k | |
| Additional Supplementary Disclosures | |||||||
| Additional Supplementary Disclosures | |||||||
| Operating lease liabilities | — | ($270k) | ($345k) | ($458k) | ($460k) | — | |
| Additional Financial Items | |||||||
| Foreign Currency Transaction Gain (Loss), Unrealized | — | — | $206k | ($218k) | $546k | — | |
| General and Administrative Expense | — | — | $14.0m | $10.8m | $26.6m | — | |
| Operating Expenses | — | — | $24.5m | $33.3m | $44.3m | — | |
| Allowance for credit losses | — | $323k | $185k | $127k | $825k | — | |
| Reduction in the carrying amount of right-of-use assets | — | $272k | $318k | $421k | $527k | — | |
| Changes in fair value of financial instruments | — | $191k | $1.5m | $88k | ($128k) | — | |
| Unrealized foreign currency transaction (gain) loss | — | ($423k) | ($206k) | $218k | ($546k) | — | |
| Amounts due from related parties | — | ($256k) | ($469k) | ($1.3m) | ($745k) | — | |
| Contract liabilities | — | $1.2m | ($1.5m) | $2.0m | $711k | — | |
| Amounts due to a related party | — | — | — | $127k | $35k | — | |
| Other non-current liabilities | — | ($8k) | $72k | $89k | ($80k) | — | |
| Proceeds from collection of the loan to a related party of a shareholder | — | $1.4m | $2.9m | $56k | — | — | |
| Interest free advances to the Founders and executive officers | — | ($244k) | ($705k) | — | — | — | |
| Proceeds from collection of advances to the Founders and executive officers | — | — | $272k | $676k | — | — | |
| Payments of initial public offering ("IPO") cost | — | ($121k) | ($1.5m) | ($1.9m) | $1.8m | — | |
| Accrual of IPO cost | — | $198k | — | $1.2m | — | — | |
| Accrual of IPO and follow-up offering cost | — | — | — | $1.2m | $523k | — | |
| Cash Flow From Continuing Financing Activities | — | $2.3m | $10.7m | $19.1m | ($4.3m) | ($4.3m) | |
| Cash Flow From Continuing Investing Activities | — | $1.2m | $2.3m | ($534k) | ($1.5m) | ($1.5m) | |
| Change In Account Payable | — | $4.1m | ($860k) | $2.4m | ($2.1m) | ($2.1m) | |
| Change In Other Working Capital | — | $1.2m | ($1.5m) | $2.0m | $711k | $711k | |
| Change In Payable | — | $4.1m | ($860k) | $2.5m | ($2.1m) | ($2.1m) | |
| Change In Prepaid Assets | — | ($410k) | $167k | ($4.7m) | $2.9m | $2.9m | |
| Changes In Cash | — | $4.3m | $7.4m | $11.4m | ($13.4m) | ($13.4m) | |
| End Cash Position | — | $8.7m | $15.7m | $26.8m | $13.9m | $13.9m | |
| Financing Cash Flow | — | $2.3m |
$10.7m
+371.57%
|
$19.1m
+78.25%
|
($4.3m)
-122.60%
|
($4.3m)
0.00%
|
|
| Free Cash Flow | — | $635k | ($6.1m) | ($7.8m) | ($8.2m) | ($8.2m) | |
| Gain Loss On Sale Of PPE | — | $8k | $2k | $0 | $0 | $0 | |
| Investing Cash Flow | — | $1.2m | $2.3m | ($534k) | ($1.5m) | ($1.5m) | |
| Net Foreign Currency Exchange Gain Loss | — | ($423k) | ($206k) | $218k | ($546k) | ($546k) | |
| Net PPE Purchase And Sale | — | ($214k) | ($526k) | ($614k) | ($677k) | ($677k) | |
| Net Preferred Stock Issuance | $15.9m | $0 | $0 | — | — | — | |
| Operating Gains Losses | — | ($415k) | ($204k) | ($15k) | ($546k) | ($546k) | |
| Other Non Cash Items | $219k | ($72k) | — | — | $12k | — | |
| Preferred Stock Issuance | $16.1m | $0 | $0 | — | — | — | |
| Preferred Stock Payments | ($181k) | $0 | $0 | — | — | — | |
| Provisionand Write Offof Assets | — | $323k | $185k | $127k | $825k | $825k | |
| Purchase Of PPE | — | ($214k) | ($526k) | ($614k) | ($677k) | ($677k) | |
| Stock Based Compensation | — | $0 | $7.5m | $7.0m | $20.9m | $20.9m | |
| Unrealized Gain Loss On Investment Securities | — | $191k | $1.5m | $88k | ($128k) | ($128k) | |
| Supplemental disclosure of cash flow information: | |||||||
| Change In Cash Supplemental As Reported | — | $3.8m | $7.0m | $11.1m | ($12.9m) | — | |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | $119k | $77k | $213k | $128k | — | |
| Income Taxes Paid, Net | — | $0 | $0 | $83k | $45k | — |